睡眠関連運動障害治療薬の世界市場2020:企業別、地域別、種類・用途別

【英語タイトル】Global Sleep Movement Disorder Drug Market 2020 by Company, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが出版した調査資料(GIR20OC10327)・商品コード:GIR20OC10327
・発行会社(調査会社):GlobalInfoResearch
・発行日:2020年10月
・ページ数:103
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥396,720見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥595,080見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥793,440見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本書では、睡眠関連運動障害治療薬の世界市場を調査対象にし、睡眠関連運動障害治療薬の市場概要、企業情報、企業別売上・市場シェア、地域別市場分析(北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ)、種類別分析(ベンゾジアゼピン、オピオイド、抗痙攣薬、その他)、用途別分析(病院薬局、小売薬局、オンライン薬局)、市場予測(2021年~2025年)情報などを整理しました。
・市場概要
・企業情報:Cardinal Health、GlaxoSmithKline、Shermco、Mylan、Pfizer、Teva、Allergan、Vollin Holdings、BD
・企業別売上、市場シェア
・睡眠関連運動障害治療薬の地域別市場分析
・睡眠関連運動障害治療薬の北米市場規模2015-2020:アメリカ、カナダ、メキシコ
・睡眠関連運動障害治療薬のヨーロッパ市場規模2015-2020:ドイツ、イギリス、フランス、ロシアなど
・睡眠関連運動障害治療薬のアジア市場規模2015-2020:日本、中国、韓国、インド、東南アジアなど
・睡眠関連運動障害治療薬の南米市場規模2015-2020:ブラジル、アルゼンチンなど
・睡眠関連運動障害治療薬の中東・アフリカ市場規模2015-2020:サウジアラビア、トルコ、エジプト、南アフリカなど
・睡眠関連運動障害治療薬の種類別市場規模2015-2020:ベンゾジアゼピン、オピオイド、抗痙攣薬、その他
・睡眠関連運動障害治療薬の用途別市場規模2015-2020:病院薬局、小売薬局、オンライン薬局
・睡眠関連運動障害治療薬の世界市場予測2021-2025:地域別、種類別、用途別
・調査の結果・結論
【レポートの概要】

Market Overview
The global Sleep Movement Disorder Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Sleep Movement Disorder Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Sleep Movement Disorder Drug market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Sleep Movement Disorder Drug market has been segmented into:
Benzodiazepines
Opioids
Anticonvulsants
Others

By Application, Sleep Movement Disorder Drug has been segmented into:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Sleep Movement Disorder Drug market presented in the report. This section sheds light on the sales growth of different regional and country-level Sleep Movement Disorder Drug markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Sleep Movement Disorder Drug market.

The report offers in-depth assessment of the growth and other aspects of the Sleep Movement Disorder Drug market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Sleep Movement Disorder Drug Market Share Analysis
Sleep Movement Disorder Drug competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Sleep Movement Disorder Drug sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Sleep Movement Disorder Drug sales, revenue and market share for each player covered in this report.

The major players covered in Sleep Movement Disorder Drug are:
Cardinal Health
GlaxoSmithKline
Shermco
Mylan
Pfizer
Teva
Allergan
Vollin Holdings
BD

【レポートの目次】

Table of Contents

1 Sleep Movement Disorder Drug Market Overview
1.1 Product Overview and Scope of Sleep Movement Disorder Drug
1.2 Classification of Sleep Movement Disorder Drug by Type
1.2.1 Global Sleep Movement Disorder Drug Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Sleep Movement Disorder Drug Revenue Market Share by Type in 2019
1.2.3 Benzodiazepines
1.2.4 Opioids
1.2.5 Anticonvulsants
1.2.6 Others
1.3 Global Sleep Movement Disorder Drug Market by Application
1.3.1 Overview: Global Sleep Movement Disorder Drug Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Sleep Movement Disorder Drug Market by Regions
1.4.1 Global Sleep Movement Disorder Drug Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Sleep Movement Disorder Drug (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Sleep Movement Disorder Drug Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Sleep Movement Disorder Drug Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Sleep Movement Disorder Drug Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Sleep Movement Disorder Drug Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Sleep Movement Disorder Drug Status and Prospect (2015-2025)
2 Company Profiles
2.1 Cardinal Health
2.1.1 Cardinal Health Details
2.1.2 Cardinal Health Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Cardinal Health SWOT Analysis
2.1.4 Cardinal Health Product and Services
2.1.5 Cardinal Health Sleep Movement Disorder Drug Revenue, Gross Margin and Market Share (2018-2019)
2.2 GlaxoSmithKline
2.2.1 GlaxoSmithKline Details
2.2.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 GlaxoSmithKline SWOT Analysis
2.2.4 GlaxoSmithKline Product and Services
2.2.5 GlaxoSmithKline Sleep Movement Disorder Drug Revenue, Gross Margin and Market Share (2018-2019)
2.3 Shermco
2.3.1 Shermco Details
2.3.2 Shermco Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Shermco SWOT Analysis
2.3.4 Shermco Product and Services
2.3.5 Shermco Sleep Movement Disorder Drug Revenue, Gross Margin and Market Share (2018-2019)
2.4 Mylan
2.4.1 Mylan Details
2.4.2 Mylan Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Mylan SWOT Analysis
2.4.4 Mylan Product and Services
2.4.5 Mylan Sleep Movement Disorder Drug Revenue, Gross Margin and Market Share (2018-2019)
2.5 Pfizer
2.5.1 Pfizer Details
2.5.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Pfizer SWOT Analysis
2.5.4 Pfizer Product and Services
2.5.5 Pfizer Sleep Movement Disorder Drug Revenue, Gross Margin and Market Share (2018-2019)
2.6 Teva
2.6.1 Teva Details
2.6.2 Teva Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Teva SWOT Analysis
2.6.4 Teva Product and Services
2.6.5 Teva Sleep Movement Disorder Drug Revenue, Gross Margin and Market Share (2018-2019)
2.7 Allergan
2.7.1 Allergan Details
2.7.2 Allergan Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Allergan SWOT Analysis
2.7.4 Allergan Product and Services
2.7.5 Allergan Sleep Movement Disorder Drug Revenue, Gross Margin and Market Share (2018-2019)
2.8 Vollin Holdings
2.8.1 Vollin Holdings Details
2.8.2 Vollin Holdings Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Vollin Holdings SWOT Analysis
2.8.4 Vollin Holdings Product and Services
2.8.5 Vollin Holdings Sleep Movement Disorder Drug Revenue, Gross Margin and Market Share (2018-2019)
2.9 BD
2.9.1 BD Details
2.9.2 BD Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 BD SWOT Analysis
2.9.4 BD Product and Services
2.9.5 BD Sleep Movement Disorder Drug Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Sleep Movement Disorder Drug Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Sleep Movement Disorder Drug Players Market Share
3.2.2 Top 10 Sleep Movement Disorder Drug Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Sleep Movement Disorder Drug Revenue and Market Share by Regions
4.2 North America Sleep Movement Disorder Drug Revenue and Growth Rate (2015-2020)
4.3 Europe Sleep Movement Disorder Drug Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Sleep Movement Disorder Drug Revenue and Growth Rate (2015-2020)
4.5 South America Sleep Movement Disorder Drug Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Sleep Movement Disorder Drug Revenue and Growth Rate (2015-2020)
5 North America Sleep Movement Disorder Drug Revenue by Countries
5.1 North America Sleep Movement Disorder Drug Revenue by Countries (2015-2020)
5.2 USA Sleep Movement Disorder Drug Revenue and Growth Rate (2015-2020)
5.3 Canada Sleep Movement Disorder Drug Revenue and Growth Rate (2015-2020)
5.4 Mexico Sleep Movement Disorder Drug Revenue and Growth Rate (2015-2020)
6 Europe Sleep Movement Disorder Drug Revenue by Countries
6.1 Europe Sleep Movement Disorder Drug Revenue by Countries (2015-2020)
6.2 Germany Sleep Movement Disorder Drug Revenue and Growth Rate (2015-2020)
6.3 UK Sleep Movement Disorder Drug Revenue and Growth Rate (2015-2020)
6.4 France Sleep Movement Disorder Drug Revenue and Growth Rate (2015-2020)
6.5 Russia Sleep Movement Disorder Drug Revenue and Growth Rate (2015-2020)
6.6 Italy Sleep Movement Disorder Drug Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Sleep Movement Disorder Drug Revenue by Countries
7.1 Asia-Pacific Sleep Movement Disorder Drug Revenue by Countries (2015-2020)
7.2 China Sleep Movement Disorder Drug Revenue and Growth Rate (2015-2020)
7.3 Japan Sleep Movement Disorder Drug Revenue and Growth Rate (2015-2020)
7.4 Korea Sleep Movement Disorder Drug Revenue and Growth Rate (2015-2020)
7.5 India Sleep Movement Disorder Drug Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Sleep Movement Disorder Drug Revenue and Growth Rate (2015-2020)
8 South America Sleep Movement Disorder Drug Revenue by Countries
8.1 South America Sleep Movement Disorder Drug Revenue by Countries (2015-2020)
8.2 Brazil Sleep Movement Disorder Drug Revenue and Growth Rate (2015-2020)
8.3 Argentina Sleep Movement Disorder Drug Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Sleep Movement Disorder Drug by Countries
9.1 Middle East & Africa Sleep Movement Disorder Drug Revenue by Countries (2015-2020)
9.2 Saudi Arabia Sleep Movement Disorder Drug Revenue and Growth Rate (2015-2020)
9.3 UAE Sleep Movement Disorder Drug Revenue and Growth Rate (2015-2020)
9.4 Egypt Sleep Movement Disorder Drug Revenue and Growth Rate (2015-2020)
9.5 South Africa Sleep Movement Disorder Drug Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Sleep Movement Disorder Drug Revenue and Market Share by Type (2015-2020)
10.2 Global Sleep Movement Disorder Drug Market Forecast by Type (2019-2024)
10.3 Benzodiazepines Revenue Growth Rate (2015-2025)
10.4 Opioids Revenue Growth Rate (2015-2025)
10.5 Anticonvulsants Revenue Growth Rate (2015-2025)
10.6 Others Revenue Growth Rate (2015-2025)
11 Global Sleep Movement Disorder Drug Market Segment by Application
11.1 Global Sleep Movement Disorder Drug Revenue Market Share by Application (2015-2020)
11.2 Sleep Movement Disorder Drug Market Forecast by Application (2019-2024)
11.3 Hospital Pharmacies Revenue Growth (2015-2020)
11.4 Retail Pharmacies Revenue Growth (2015-2020)
11.5 Online Pharmacies Revenue Growth (2015-2020)
12 Global Sleep Movement Disorder Drug Market Size Forecast (2021-2025)
12.1 Global Sleep Movement Disorder Drug Market Size Forecast (2021-2025)
12.2 Global Sleep Movement Disorder Drug Market Forecast by Regions (2021-2025)
12.3 North America Sleep Movement Disorder Drug Revenue Market Forecast (2021-2025)
12.4 Europe Sleep Movement Disorder Drug Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Sleep Movement Disorder Drug Revenue Market Forecast (2021-2025)
12.6 South America Sleep Movement Disorder Drug Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Sleep Movement Disorder Drug Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global Sleep Movement Disorder Drug Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Sleep Movement Disorder Drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Sleep Movement Disorder Drug Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Sleep Movement Disorder Drug Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Cardinal Health Corporate Information, Location and Competitors
Table 6. Cardinal Health Sleep Movement Disorder Drug Major Business
Table 7. Cardinal Health Sleep Movement Disorder Drug Total Revenue (USD Million) (2017-2018)
Table 8. Cardinal Health SWOT Analysis
Table 9. Cardinal Health Sleep Movement Disorder Drug Product and Solutions
Table 10. Cardinal Health Sleep Movement Disorder Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. GlaxoSmithKline Corporate Information, Location and Competitors
Table 12. GlaxoSmithKline Sleep Movement Disorder Drug Major Business
Table 13. GlaxoSmithKline Sleep Movement Disorder Drug Total Revenue (USD Million) (2018-2019)
Table 14. GlaxoSmithKline SWOT Analysis
Table 15. GlaxoSmithKline Sleep Movement Disorder Drug Product and Solutions
Table 16. GlaxoSmithKline Sleep Movement Disorder Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Shermco Corporate Information, Location and Competitors
Table 18. Shermco Sleep Movement Disorder Drug Major Business
Table 19. Shermco Sleep Movement Disorder Drug Total Revenue (USD Million) (2017-2018)
Table 20. Shermco SWOT Analysis
Table 21. Shermco Sleep Movement Disorder Drug Product and Solutions
Table 22. Shermco Sleep Movement Disorder Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Mylan Corporate Information, Location and Competitors
Table 24. Mylan Sleep Movement Disorder Drug Major Business
Table 25. Mylan Sleep Movement Disorder Drug Total Revenue (USD Million) (2017-2018)
Table 26. Mylan SWOT Analysis
Table 27. Mylan Sleep Movement Disorder Drug Product and Solutions
Table 28. Mylan Sleep Movement Disorder Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Pfizer Corporate Information, Location and Competitors
Table 30. Pfizer Sleep Movement Disorder Drug Major Business
Table 31. Pfizer Sleep Movement Disorder Drug Total Revenue (USD Million) (2017-2018)
Table 32. Pfizer SWOT Analysis
Table 33. Pfizer Sleep Movement Disorder Drug Product and Solutions
Table 34. Pfizer Sleep Movement Disorder Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Teva Corporate Information, Location and Competitors
Table 36. Teva Sleep Movement Disorder Drug Major Business
Table 37. Teva Sleep Movement Disorder Drug Total Revenue (USD Million) (2017-2018)
Table 38. Teva SWOT Analysis
Table 39. Teva Sleep Movement Disorder Drug Product and Solutions
Table 40. Teva Sleep Movement Disorder Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Allergan Corporate Information, Location and Competitors
Table 42. Allergan Sleep Movement Disorder Drug Major Business
Table 43. Allergan Sleep Movement Disorder Drug Total Revenue (USD Million) (2017-2018)
Table 44. Allergan SWOT Analysis
Table 45. Allergan Sleep Movement Disorder Drug Product and Solutions
Table 46. Allergan Sleep Movement Disorder Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Vollin Holdings Corporate Information, Location and Competitors
Table 48. Vollin Holdings Sleep Movement Disorder Drug Major Business
Table 49. Vollin Holdings Sleep Movement Disorder Drug Total Revenue (USD Million) (2017-2018)
Table 50. Vollin Holdings SWOT Analysis
Table 51. Vollin Holdings Sleep Movement Disorder Drug Product and Solutions
Table 52. Vollin Holdings Sleep Movement Disorder Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. BD Corporate Information, Location and Competitors
Table 54. BD Sleep Movement Disorder Drug Major Business
Table 55. BD Sleep Movement Disorder Drug Total Revenue (USD Million) (2017-2018)
Table 56. BD SWOT Analysis
Table 57. BD Sleep Movement Disorder Drug Product and Solutions
Table 58. BD Sleep Movement Disorder Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Global Sleep Movement Disorder Drug Revenue (Million USD) by Players (2015-2020)
Table 60. Global Sleep Movement Disorder Drug Revenue Share by Players (2015-2020)
Table 61. Global Sleep Movement Disorder Drug Revenue (Million USD) by Regions (2015-2020)
Table 62. Global Sleep Movement Disorder Drug Revenue Market Share by Regions (2015-2020)
Table 63. North America Sleep Movement Disorder Drug Revenue by Countries (2015-2020)
Table 64. North America Sleep Movement Disorder Drug Revenue Market Share by Countries (2015-2020)
Table 65. Europe Sleep Movement Disorder Drug Revenue (Million USD) by Countries (2015-2020)
Table 66. Asia-Pacific Sleep Movement Disorder Drug Revenue (Million USD) by Countries (2015-2020)
Table 67. South America Sleep Movement Disorder Drug Revenue by Countries (2015-2020)
Table 68. South America Sleep Movement Disorder Drug Revenue Market Share by Countries (2015-2020)
Table 69. Middle East and Africa Sleep Movement Disorder Drug Revenue (Million USD) by Countries (2015-2020)
Table 70. Middle East and Africa Sleep Movement Disorder Drug Revenue Market Share by Countries (2015-2020)
Table 71. Global Sleep Movement Disorder Drug Revenue (Million USD) by Type (2015-2020)
Table 72. Global Sleep Movement Disorder Drug Revenue Share by Type (2015-2020)
Table 73. Global Sleep Movement Disorder Drug Revenue Forecast by Type (2021-2025)
Table 74. Global Sleep Movement Disorder Drug Revenue by Application (2015-2020)
Table 75. Global Sleep Movement Disorder Drug Revenue Share by Application (2015-2020)
Table 76. Global Sleep Movement Disorder Drug Revenue Forecast by Application (2021-2025)
Table 77. Global Sleep Movement Disorder Drug Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Sleep Movement Disorder Drug Picture
Figure 2. Global Sleep Movement Disorder Drug Revenue Market Share by Type in 2019
Figure 3. Benzodiazepines Picture
Figure 4. Opioids Picture
Figure 5. Anticonvulsants Picture
Figure 6. Others Picture
Figure 7. Sleep Movement Disorder Drug Revenue Market Share by Application in 2019
Figure 8. Hospital Pharmacies Picture
Figure 9. Retail Pharmacies Picture
Figure 10. Online Pharmacies Picture
Figure 11. Global Sleep Movement Disorder Drug Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America Sleep Movement Disorder Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe Sleep Movement Disorder Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific Sleep Movement Disorder Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America Sleep Movement Disorder Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa Sleep Movement Disorder Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Sleep Movement Disorder Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Sleep Movement Disorder Drug Revenue Share by Players in 2019
Figure 19. Global Top 5 Players Sleep Movement Disorder Drug Revenue Market Share in 2019
Figure 20. Global Top 10 Players Sleep Movement Disorder Drug Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global Sleep Movement Disorder Drug Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global Sleep Movement Disorder Drug Revenue Market Share by Regions (2015-2020)
Figure 24. Global Sleep Movement Disorder Drug Revenue Market Share by Regions in 2018
Figure 25. North America Sleep Movement Disorder Drug Revenue and Growth Rate (2015-2020)
Figure 26. Europe Sleep Movement Disorder Drug Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific Sleep Movement Disorder Drug Revenue and Growth Rate (2015-2020)
Figure 28. South America Sleep Movement Disorder Drug Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa Sleep Movement Disorder Drug Revenue and Growth Rate (2015-2020)
Figure 30. North America Sleep Movement Disorder Drug Revenue Market Share by Countries (2015-2020)
Figure 31. North America Sleep Movement Disorder Drug Revenue Market Share by Countries in 2019
Figure 32. USA Sleep Movement Disorder Drug Revenue and Growth Rate (2015-2020)
Figure 33. Canada Sleep Movement Disorder Drug Revenue and Growth Rate (2015-2020)
Figure 34. Mexico Sleep Movement Disorder Drug Revenue and Growth Rate (2015-2020)
Figure 35. Europe Sleep Movement Disorder Drug Revenue Market Share by Countries (2015-2020)
Figure 36. Europe Sleep Movement Disorder Drug Revenue Market Share by Countries in 2019
Figure 37. Germany Sleep Movement Disorder Drug Revenue and Growth Rate (2015-2020)
Figure 38. UK Sleep Movement Disorder Drug Revenue and Growth Rate (2015-2020)
Figure 39. France Sleep Movement Disorder Drug Revenue and Growth Rate (2015-2020)
Figure 40. Russia Sleep Movement Disorder Drug Revenue and Growth Rate (2015-2020)
Figure 41. Italy Sleep Movement Disorder Drug Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Sleep Movement Disorder Drug Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific Sleep Movement Disorder Drug Revenue Market Share by Countries in 2019
Figure 44. China Sleep Movement Disorder Drug Revenue and Growth Rate (2015-2020)
Figure 45. Japan Sleep Movement Disorder Drug Revenue and Growth Rate (2015-2020)
Figure 46. Korea Sleep Movement Disorder Drug Revenue and Growth Rate (2015-2020)
Figure 47. India Sleep Movement Disorder Drug Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia Sleep Movement Disorder Drug Revenue and Growth Rate (2015-2020)
Figure 49. South America Sleep Movement Disorder Drug Revenue Market Share by Countries (2015-2020)
Figure 50. South America Sleep Movement Disorder Drug Revenue Market Share by Countries in 2019
Figure 51. Brazil Sleep Movement Disorder Drug Revenue and Growth Rate (2015-2020)
Figure 52. Argentina Sleep Movement Disorder Drug Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa Sleep Movement Disorder Drug Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa Sleep Movement Disorder Drug Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia Sleep Movement Disorder Drug Revenue and Growth Rate (2015-2020)
Figure 56. UAE Sleep Movement Disorder Drug Revenue and Growth Rate (2015-2020)
Figure 57. Egypt Sleep Movement Disorder Drug Revenue and Growth Rate (2015-2020)
Figure 58. South Africa Sleep Movement Disorder Drug Revenue and Growth Rate (2015-2020)
Figure 59. Global Sleep Movement Disorder Drug Revenue Share by Type (2015-2020)
Figure 60. Global Sleep Movement Disorder Drug Revenue Share by Type in 2019
Figure 61. Global Sleep Movement Disorder Drug Market Share Forecast by Type (2021-2025)
Figure 62. Global Benzodiazepines Revenue Growth Rate (2015-2020)
Figure 63. Global Opioids Revenue Growth Rate (2015-2020)
Figure 64. Global Anticonvulsants Revenue Growth Rate (2015-2020)
Figure 65. Global Others Revenue Growth Rate (2015-2020)
Figure 66. Global Sleep Movement Disorder Drug Revenue Share by Application (2015-2020)
Figure 67. Global Sleep Movement Disorder Drug Revenue Share by Application in 2019
Figure 68. Global Sleep Movement Disorder Drug Market Share Forecast by Application (2021-2025)
Figure 69. Global Hospital Pharmacies Revenue Growth Rate (2015-2020)
Figure 70. Global Retail Pharmacies Revenue Growth Rate (2015-2020)
Figure 71. Global Online Pharmacies Revenue Growth Rate (2015-2020)
Figure 72. Global Sleep Movement Disorder Drug Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global Sleep Movement Disorder Drug Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global Sleep Movement Disorder Drug Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America Sleep Movement Disorder Drug Revenue Market Forecast (2021-2025)
Figure 76. Europe Sleep Movement Disorder Drug Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific Sleep Movement Disorder Drug Revenue Market Forecast (2021-2025)
Figure 78. South America Sleep Movement Disorder Drug Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa Sleep Movement Disorder Drug Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel


【掲載企業】

Cardinal Health、GlaxoSmithKline、Shermco、Mylan、Pfizer、Teva、Allergan、Vollin Holdings、BD

★調査レポート[睡眠関連運動障害治療薬の世界市場2020:企業別、地域別、種類・用途別] (コード:GIR20OC10327)販売に関する免責事項を必ずご確認ください。
★調査レポート[睡眠関連運動障害治療薬の世界市場2020:企業別、地域別、種類・用途別]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆